Drug intelligence / Profile preview

Bv-NVD-R

Development stage: Unknown
Modality: Vaccines & Immunotherapeutics, Cytotoxic ADCs → Antibody-Drug Conjugates (ADCs) → Antibody Conjugates → Antibody-Based Therapeutics, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
Administration: Intravenous

Overview

Bv-NVD-R is a targeted immunotherapy combination regimen consisting of brentuximab vedotin (Bv), nivolumab (N), vinblastine (V), dacarbazine (D), and rituximab (R). This combination therapy is being studied in clinical trials for treating classical Hodgkin lymphoma (cHL) in pediatric, adolescent, and young adult patients. The regimen is part of a risk-adapted approach to treatment, where patients are classified as either Rapid Early Responders (RER) or Slow Early Responders (SER) based on FDG-PET scan results after initial treatment cycles. This classification determines the subsequent treatment protocol.

Other names: Bv-NVD-R regimen

Targets

CD30 (CD30 antigen)TUBB (Tubulin (alpha and beta subunits))

Beyond the preview

Go deeper on Bv-NVD-R.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bv-NVD-R.

Explore the full profile